Cardiotoxicity represents a rising problem influencing prognosis and quality of life of
chemotherapy‐treated patients. Anthracyclines and trastuzumab are the drugs most …

The evaluation by cardiovascular imaging of chemotherapy patients became a central topic
in the last several years. The use of drugs for the treatment of cancers increased, and new …

Cancer therapy can be associated with both cardiac and vascular toxicity. Advanced multi-
modality imaging can be used to stratify patient risk, identify cardiovascular injury during and …

Opinion Statement New advances in cancer diagnosis and treatment have increased
survival rates in patients with cancer. In parallel with this increase in the number of cancer …

Cancer therapeutics induced cardiotoxicity has emerged as an important factor of long-term
adverse cardiovascular outcomes in survivors of various malignant diseases. Early detection …

Recently, the field of oncology has witnessed a surge of new therapeutic agents that have
collectively led to improved rates of progression-free and overall survival for many cancers …

Abstract Purpose of Review In the last decades, there have been great advances made in
cancer diagnosis and treatment, giving a reduction in mortality, an increase in survival, and …

Chemotherapy-induced cardiotoxicity remains a significant and unresolved issue in treating
adult and pediatric cancer patients. Current approaches to surveillance are often inadequate …

The population of patients with cancer is rapidly expanding, and the diagnosis and
monitoring of cardiovascular complications greatly rely on imaging. Numerous advances in …

Opinion statement Recent advances in cancer treatment and research have greatly
improved survival rates for patients with cancer. However, many of these cancer survivors …